Incorporating the patient perspective into clinical trial protocol design and endpoint selection is essential for ensuring that trials are relevant and meaningful. However, this integration presents challenges, including finding common ground among stakeholders and navigating the balance between scientific rigor and feasibility. This session will explore how pharma companies can streamline protocols while maintaining their integrity and enhancing patient engagement
- Understand the importance of the patient voice in clinical trial design and endpoint selection.
- Identify challenges in balancing scientific and Regulatory rigor, feasibility, and patient-centricity.
- Explore strategies for creating streamlined protocols without compromising essential data collection.
- Discuss best practices for enhancing collaboration within trial teams to facilitate patient-centered design
Moderator: Estrella Garcia, Executive Global Clinical Operations Director, ALMIRALL
Panellists: Denis Costello, Director at CML Advocates Network & Board Member
Laia Bisbal Arnal, Open Classroom Coordinator, EUPATI